Stock listing

51S Stock Price, News, Filings & Events — Cynata Therapeutics Limited

Selected listing: 51S · FWB · EUR · DE

The 51S:FWB listing represents Cynata Therapeutics Limited, a biotechnology company focused on developing and commercializing innovative cell therapies. Cynata's proprietary Cymerus technology enables the production of therapeutic cells from induced pluripotent stem cells, which has significant implications for treating various diseases. Recent news highlights the company's advancements in clinical trials and collaborations aimed at enhancing its product pipeline. Investors can stay informed about upcoming events and regulatory filings that may impact the company's market position.

51S:FWBEURDEUpdated July 24, 2026
Cynata Therapeutics Limited logo
Ticker
51S:FWB
Asset type
Stock
Market cap
$2.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
FWB
Currency
EUR

Cynata Therapeutics Limited 51S:FWB stock context

The 51S:FWB listing represents Cynata Therapeutics Limited, a biotechnology company focused on developing and commercializing innovative cell therapies. Cynata's proprietary Cymerus technology enables the production of therapeutic cells from induced pluripotent stem cells, which has significant implications for treating various diseases. Recent news highlights the company's advancements in clinical trials and collaborations aimed at enhancing its product pipeline. Investors can stay informed about upcoming events and regulatory filings that may impact the company's market position.

Research Cynata Therapeutics Limited

Alternate listings